nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Methylprednisolone—multiple sclerosis	0.0709	0.103	CbGbCtD
Etravirine—CYP3A4—Fingolimod—multiple sclerosis	0.0659	0.0958	CbGbCtD
Etravirine—CYP2C19—Prednisone—multiple sclerosis	0.0532	0.0774	CbGbCtD
Etravirine—ABCB1—Mitoxantrone—multiple sclerosis	0.0517	0.0752	CbGbCtD
Etravirine—ABCB1—Betamethasone—multiple sclerosis	0.0461	0.067	CbGbCtD
Etravirine—ABCB1—Prednisolone—multiple sclerosis	0.0455	0.0661	CbGbCtD
Etravirine—ABCB1—Prednisone—multiple sclerosis	0.0429	0.0624	CbGbCtD
Etravirine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0425	0.0618	CbGbCtD
Etravirine—CYP2C19—Dexamethasone—multiple sclerosis	0.0332	0.0483	CbGbCtD
Etravirine—CYP3A4—Triamcinolone—multiple sclerosis	0.0322	0.0468	CbGbCtD
Etravirine—CYP3A4—Mitoxantrone—multiple sclerosis	0.031	0.0451	CbGbCtD
Etravirine—CYP2C9—Dexamethasone—multiple sclerosis	0.0276	0.0402	CbGbCtD
Etravirine—CYP3A4—Betamethasone—multiple sclerosis	0.0276	0.0402	CbGbCtD
Etravirine—CYP3A4—Prednisolone—multiple sclerosis	0.0272	0.0396	CbGbCtD
Etravirine—ABCB1—Dexamethasone—multiple sclerosis	0.0268	0.039	CbGbCtD
Etravirine—CYP3A4—Prednisone—multiple sclerosis	0.0257	0.0374	CbGbCtD
Etravirine—ABCB1—Methotrexate—multiple sclerosis	0.0215	0.0313	CbGbCtD
Etravirine—CYP3A4—Dexamethasone—multiple sclerosis	0.0161	0.0234	CbGbCtD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00468	0.15	CbGpPWpGaD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00468	0.15	CbGpPWpGaD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00153	0.0492	CbGpPWpGaD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000602	0.0194	CbGpPWpGaD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000602	0.0194	CbGpPWpGaD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000562	0.0181	CbGpPWpGaD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000562	0.0181	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000491	0.0158	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000491	0.0158	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000392	0.0126	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000392	0.0126	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000386	0.0124	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000386	0.0124	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000371	0.0119	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000371	0.0119	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000357	0.0115	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000357	0.0115	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000352	0.0113	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000352	0.0113	CbGpPWpGaD
Etravirine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000343	0.011	CbGpPWpGaD
Etravirine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000328	0.0106	CbGpPWpGaD
Etravirine—Discomfort—Prednisolone—multiple sclerosis	0.000324	0.00115	CcSEcCtD
Etravirine—Angioedema—Triamcinolone—multiple sclerosis	0.000324	0.00115	CcSEcCtD
Etravirine—Angioedema—Methylprednisolone—multiple sclerosis	0.000323	0.00115	CcSEcCtD
Etravirine—Malaise—Triamcinolone—multiple sclerosis	0.000319	0.00114	CcSEcCtD
Etravirine—Malaise—Methylprednisolone—multiple sclerosis	0.000319	0.00113	CcSEcCtD
Etravirine—Vertigo—Triamcinolone—multiple sclerosis	0.000318	0.00113	CcSEcCtD
Etravirine—Syncope—Triamcinolone—multiple sclerosis	0.000318	0.00113	CcSEcCtD
Etravirine—Vertigo—Methylprednisolone—multiple sclerosis	0.000318	0.00113	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000317	0.0102	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000317	0.0102	CbGpPWpGaD
Etravirine—Syncope—Methylprednisolone—multiple sclerosis	0.000317	0.00113	CcSEcCtD
Etravirine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000316	0.00112	CcSEcCtD
Etravirine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000316	0.00112	CcSEcCtD
Etravirine—Dizziness—Azathioprine—multiple sclerosis	0.000313	0.00111	CcSEcCtD
Etravirine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000313	0.00111	CcSEcCtD
Etravirine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000311	0.00111	CcSEcCtD
Etravirine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000311	0.0011	CcSEcCtD
Etravirine—ABCB4—Metabolism—SRM—multiple sclerosis	0.000311	0.00998	CbGpPWpGaD
Etravirine—Shock—Prednisolone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Etravirine—Convulsion—Triamcinolone—multiple sclerosis	0.000307	0.00109	CcSEcCtD
Etravirine—Convulsion—Methylprednisolone—multiple sclerosis	0.000306	0.00109	CcSEcCtD
Etravirine—Hypertension—Triamcinolone—multiple sclerosis	0.000306	0.00109	CcSEcCtD
Etravirine—Hypertension—Methylprednisolone—multiple sclerosis	0.000305	0.00108	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000304	0.00108	CcSEcCtD
Etravirine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000303	0.00108	CcSEcCtD
Etravirine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000303	0.00108	CcSEcCtD
Etravirine—Vomiting—Azathioprine—multiple sclerosis	0.000301	0.00107	CcSEcCtD
Etravirine—Eye disorder—Prednisone—multiple sclerosis	0.000301	0.00107	CcSEcCtD
Etravirine—Anxiety—Methylprednisolone—multiple sclerosis	0.0003	0.00107	CcSEcCtD
Etravirine—Rash—Azathioprine—multiple sclerosis	0.000299	0.00106	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000299	0.00106	CcSEcCtD
Etravirine—Dermatitis—Azathioprine—multiple sclerosis	0.000299	0.00106	CcSEcCtD
Etravirine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Etravirine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Etravirine—Discomfort—Triamcinolone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Etravirine—Discomfort—Methylprednisolone—multiple sclerosis	0.000297	0.00106	CcSEcCtD
Etravirine—Headache—Azathioprine—multiple sclerosis	0.000297	0.00106	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000297	0.00106	CcSEcCtD
Etravirine—Dry mouth—Triamcinolone—multiple sclerosis	0.000295	0.00105	CcSEcCtD
Etravirine—Renal failure—Methotrexate—multiple sclerosis	0.000294	0.00105	CcSEcCtD
Etravirine—Angioedema—Dexamethasone—multiple sclerosis	0.000294	0.00104	CcSEcCtD
Etravirine—Angioedema—Betamethasone—multiple sclerosis	0.000294	0.00104	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—multiple sclerosis	0.000292	0.00104	CcSEcCtD
Etravirine—Angiopathy—Prednisone—multiple sclerosis	0.000292	0.00104	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000291	0.00103	CcSEcCtD
Etravirine—Confusional state—Methylprednisolone—multiple sclerosis	0.000291	0.00103	CcSEcCtD
Etravirine—Immune system disorder—Prednisone—multiple sclerosis	0.00029	0.00103	CcSEcCtD
Etravirine—Malaise—Dexamethasone—multiple sclerosis	0.00029	0.00103	CcSEcCtD
Etravirine—Malaise—Betamethasone—multiple sclerosis	0.00029	0.00103	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000289	0.00931	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000289	0.00931	CbGpPWpGaD
Etravirine—Vertigo—Dexamethasone—multiple sclerosis	0.000289	0.00103	CcSEcCtD
Etravirine—Vertigo—Betamethasone—multiple sclerosis	0.000289	0.00103	CcSEcCtD
Etravirine—Syncope—Betamethasone—multiple sclerosis	0.000288	0.00102	CcSEcCtD
Etravirine—Syncope—Dexamethasone—multiple sclerosis	0.000288	0.00102	CcSEcCtD
Etravirine—Infection—Triamcinolone—multiple sclerosis	0.000287	0.00102	CcSEcCtD
Etravirine—Infection—Methylprednisolone—multiple sclerosis	0.000287	0.00102	CcSEcCtD
Etravirine—Shock—Triamcinolone—multiple sclerosis	0.000284	0.00101	CcSEcCtD
Etravirine—Insomnia—Prednisolone—multiple sclerosis	0.000284	0.00101	CcSEcCtD
Etravirine—Shock—Methylprednisolone—multiple sclerosis	0.000284	0.00101	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000283	0.00101	CcSEcCtD
Etravirine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000283	0.00101	CcSEcCtD
Etravirine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000283	0.001	CcSEcCtD
Etravirine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000283	0.001	CcSEcCtD
Etravirine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000282	0.001	CcSEcCtD
Etravirine—Paraesthesia—Prednisolone—multiple sclerosis	0.000282	0.001	CcSEcCtD
Etravirine—Mental disorder—Prednisone—multiple sclerosis	0.000282	0.001	CcSEcCtD
Etravirine—Nausea—Azathioprine—multiple sclerosis	0.000282	0.001	CcSEcCtD
Etravirine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00028	0.000996	CcSEcCtD
Etravirine—Malnutrition—Prednisone—multiple sclerosis	0.00028	0.000995	CcSEcCtD
Etravirine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00028	0.000994	CcSEcCtD
Etravirine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000279	0.000991	CcSEcCtD
Etravirine—Convulsion—Dexamethasone—multiple sclerosis	0.000279	0.00099	CcSEcCtD
Etravirine—Convulsion—Betamethasone—multiple sclerosis	0.000279	0.00099	CcSEcCtD
Etravirine—Hypertension—Betamethasone—multiple sclerosis	0.000278	0.000987	CcSEcCtD
Etravirine—Hypertension—Dexamethasone—multiple sclerosis	0.000278	0.000987	CcSEcCtD
Etravirine—Asthenia—Mitoxantrone—multiple sclerosis	0.000275	0.000977	CcSEcCtD
Etravirine—Anxiety—Dexamethasone—multiple sclerosis	0.000273	0.00097	CcSEcCtD
Etravirine—Anxiety—Betamethasone—multiple sclerosis	0.000273	0.00097	CcSEcCtD
Etravirine—Discomfort—Betamethasone—multiple sclerosis	0.00027	0.000961	CcSEcCtD
Etravirine—Discomfort—Dexamethasone—multiple sclerosis	0.00027	0.000961	CcSEcCtD
Etravirine—Pain—Prednisolone—multiple sclerosis	0.000269	0.000956	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—multiple sclerosis	0.000269	0.000955	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000265	0.000944	CcSEcCtD
Etravirine—Vision blurred—Prednisone—multiple sclerosis	0.000264	0.000938	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—multiple sclerosis	0.000263	0.000937	CcSEcCtD
Etravirine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000262	0.000932	CcSEcCtD
Etravirine—Insomnia—Triamcinolone—multiple sclerosis	0.000262	0.00093	CcSEcCtD
Etravirine—Insomnia—Methylprednisolone—multiple sclerosis	0.000261	0.000928	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000261	0.00839	CbGpPWpGaD
Etravirine—Infection—Dexamethasone—multiple sclerosis	0.000261	0.000927	CcSEcCtD
Etravirine—Infection—Betamethasone—multiple sclerosis	0.000261	0.000927	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—multiple sclerosis	0.00026	0.000923	CcSEcCtD
Etravirine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00026	0.000923	CcSEcCtD
Etravirine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000259	0.000921	CcSEcCtD
Etravirine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000259	0.000921	CcSEcCtD
Etravirine—Anaemia—Prednisone—multiple sclerosis	0.000259	0.00092	CcSEcCtD
Etravirine—Shock—Dexamethasone—multiple sclerosis	0.000258	0.000918	CcSEcCtD
Etravirine—Shock—Betamethasone—multiple sclerosis	0.000258	0.000918	CcSEcCtD
Etravirine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000257	0.000915	CcSEcCtD
Etravirine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000257	0.000915	CcSEcCtD
Etravirine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000257	0.000913	CcSEcCtD
Etravirine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000257	0.000913	CcSEcCtD
Etravirine—Angioedema—Prednisone—multiple sclerosis	0.000256	0.000909	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000254	0.000903	CcSEcCtD
Etravirine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000254	0.000902	CcSEcCtD
Etravirine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000254	0.000902	CcSEcCtD
Etravirine—Malaise—Prednisone—multiple sclerosis	0.000252	0.000897	CcSEcCtD
Etravirine—Vertigo—Prednisone—multiple sclerosis	0.000252	0.000894	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—multiple sclerosis	0.000251	0.000893	CcSEcCtD
Etravirine—Syncope—Prednisone—multiple sclerosis	0.000251	0.000892	CcSEcCtD
Etravirine—Anorexia—Dexamethasone—multiple sclerosis	0.00025	0.000889	CcSEcCtD
Etravirine—Anorexia—Betamethasone—multiple sclerosis	0.00025	0.000889	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000249	0.000887	CcSEcCtD
Etravirine—Fatigue—Triamcinolone—multiple sclerosis	0.000249	0.000886	CcSEcCtD
Etravirine—Fatigue—Methylprednisolone—multiple sclerosis	0.000249	0.000884	CcSEcCtD
Etravirine—Pain—Triamcinolone—multiple sclerosis	0.000247	0.000879	CcSEcCtD
Etravirine—Loss of consciousness—Prednisone—multiple sclerosis	0.000246	0.000875	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—multiple sclerosis	0.000244	0.000867	CcSEcCtD
Etravirine—Vomiting—Mitoxantrone—multiple sclerosis	0.000244	0.000866	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—multiple sclerosis	0.000243	0.000863	CcSEcCtD
Etravirine—Convulsion—Prednisone—multiple sclerosis	0.000243	0.000862	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000242	0.000861	CcSEcCtD
Etravirine—Hypertension—Prednisone—multiple sclerosis	0.000242	0.000859	CcSEcCtD
Etravirine—Rash—Mitoxantrone—multiple sclerosis	0.000242	0.000859	CcSEcCtD
Etravirine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000241	0.000858	CcSEcCtD
Etravirine—Headache—Mitoxantrone—multiple sclerosis	0.00024	0.000853	CcSEcCtD
Etravirine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000238	0.000847	CcSEcCtD
Etravirine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000238	0.000845	CcSEcCtD
Etravirine—Anxiety—Prednisone—multiple sclerosis	0.000238	0.000844	CcSEcCtD
Etravirine—Insomnia—Betamethasone—multiple sclerosis	0.000237	0.000844	CcSEcCtD
Etravirine—Insomnia—Dexamethasone—multiple sclerosis	0.000237	0.000844	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000237	0.000841	CcSEcCtD
Etravirine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000236	0.000839	CcSEcCtD
Etravirine—Paraesthesia—Betamethasone—multiple sclerosis	0.000236	0.000837	CcSEcCtD
Etravirine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000236	0.000837	CcSEcCtD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000236	0.00757	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000236	0.00757	CbGpPWpGaD
Etravirine—Discomfort—Prednisone—multiple sclerosis	0.000235	0.000837	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—multiple sclerosis	0.000235	0.000837	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—multiple sclerosis	0.000234	0.000832	CcSEcCtD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000232	0.00747	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000232	0.00747	CbGpPWpGaD
Etravirine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000232	0.000823	CcSEcCtD
Etravirine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000229	0.000813	CcSEcCtD
Etravirine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000228	0.000811	CcSEcCtD
Etravirine—Decreased appetite—Betamethasone—multiple sclerosis	0.000228	0.000811	CcSEcCtD
Etravirine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000228	0.000811	CcSEcCtD
Etravirine—Nausea—Mitoxantrone—multiple sclerosis	0.000228	0.000809	CcSEcCtD
Etravirine—Infection—Prednisone—multiple sclerosis	0.000227	0.000807	CcSEcCtD
Etravirine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000226	0.000805	CcSEcCtD
Etravirine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000226	0.000805	CcSEcCtD
Etravirine—Fatigue—Betamethasone—multiple sclerosis	0.000226	0.000804	CcSEcCtD
Etravirine—Fatigue—Dexamethasone—multiple sclerosis	0.000226	0.000804	CcSEcCtD
Etravirine—Shock—Prednisone—multiple sclerosis	0.000225	0.000799	CcSEcCtD
Etravirine—Pain—Betamethasone—multiple sclerosis	0.000224	0.000798	CcSEcCtD
Etravirine—Pain—Dexamethasone—multiple sclerosis	0.000224	0.000798	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—multiple sclerosis	0.000224	0.000796	CcSEcCtD
Etravirine—Skin disorder—Prednisone—multiple sclerosis	0.000222	0.000789	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000221	0.000785	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—multiple sclerosis	0.00022	0.000784	CcSEcCtD
Etravirine—ABCB4—Metabolism—CYP27B1—multiple sclerosis	0.000219	0.00703	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP24A1—multiple sclerosis	0.000219	0.00703	CbGpPWpGaD
Etravirine—Anorexia—Prednisone—multiple sclerosis	0.000218	0.000774	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000217	0.000772	CcSEcCtD
Etravirine—Anaemia—Methotrexate—multiple sclerosis	0.000216	0.000769	CcSEcCtD
Etravirine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000216	0.000769	CcSEcCtD
Etravirine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000216	0.000769	CcSEcCtD
Etravirine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000215	0.000763	CcSEcCtD
Etravirine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000215	0.000763	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000214	0.00687	CbGpPWpGaD
Etravirine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000213	0.000757	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000213	0.00684	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000213	0.00684	CbGpPWpGaD
Etravirine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000213	0.000756	CcSEcCtD
Etravirine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000211	0.00679	CbGpPWpGaD
Etravirine—Malaise—Methotrexate—multiple sclerosis	0.000211	0.00075	CcSEcCtD
Etravirine—Vertigo—Methotrexate—multiple sclerosis	0.00021	0.000747	CcSEcCtD
Etravirine—Dizziness—Prednisolone—multiple sclerosis	0.000208	0.000739	CcSEcCtD
Etravirine—Asthenia—Triamcinolone—multiple sclerosis	0.000207	0.000737	CcSEcCtD
Etravirine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000207	0.000737	CcSEcCtD
Etravirine—Abdominal pain—Betamethasone—multiple sclerosis	0.000207	0.000737	CcSEcCtD
Etravirine—Body temperature increased—Betamethasone—multiple sclerosis	0.000207	0.000737	CcSEcCtD
Etravirine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000207	0.000737	CcSEcCtD
Etravirine—Asthenia—Methylprednisolone—multiple sclerosis	0.000207	0.000736	CcSEcCtD
Etravirine—Insomnia—Prednisone—multiple sclerosis	0.000207	0.000735	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—multiple sclerosis	0.000205	0.000729	CcSEcCtD
Etravirine—Convulsion—Methotrexate—multiple sclerosis	0.000203	0.000721	CcSEcCtD
Etravirine—ABCB4—Metabolism—GPC5—multiple sclerosis	0.0002	0.00643	CbGpPWpGaD
Etravirine—Decreased appetite—Prednisone—multiple sclerosis	0.000199	0.000706	CcSEcCtD
Etravirine—Rash—Prednisolone—multiple sclerosis	0.000198	0.000705	CcSEcCtD
Etravirine—Dermatitis—Prednisolone—multiple sclerosis	0.000198	0.000704	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000198	0.000703	CcSEcCtD
Etravirine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000197	0.000702	CcSEcCtD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000197	0.00633	CbGpPWpGaD
Etravirine—Fatigue—Prednisone—multiple sclerosis	0.000197	0.0007	CcSEcCtD
Etravirine—Headache—Prednisolone—multiple sclerosis	0.000197	0.0007	CcSEcCtD
Etravirine—Discomfort—Methotrexate—multiple sclerosis	0.000197	0.0007	CcSEcCtD
Etravirine—Constipation—Prednisone—multiple sclerosis	0.000195	0.000695	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000193	0.00622	CbGpPWpGaD
Etravirine—Confusional state—Methotrexate—multiple sclerosis	0.000193	0.000684	CcSEcCtD
Etravirine—Dizziness—Triamcinolone—multiple sclerosis	0.000191	0.00068	CcSEcCtD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000191	0.00614	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000191	0.00614	CbGpPWpGaD
Etravirine—Dizziness—Methylprednisolone—multiple sclerosis	0.000191	0.000678	CcSEcCtD
Etravirine—Infection—Methotrexate—multiple sclerosis	0.00019	0.000674	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—multiple sclerosis	0.000188	0.000669	CcSEcCtD
Etravirine—Asthenia—Betamethasone—multiple sclerosis	0.000188	0.000669	CcSEcCtD
Etravirine—Asthenia—Dexamethasone—multiple sclerosis	0.000188	0.000669	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000187	0.000666	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000187	0.000665	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000187	0.000664	CcSEcCtD
Etravirine—Nausea—Prednisolone—multiple sclerosis	0.000187	0.000664	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—multiple sclerosis	0.000185	0.000659	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000185	0.000656	CcSEcCtD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000184	0.00592	CbGpPWpGaD
Etravirine—Vomiting—Triamcinolone—multiple sclerosis	0.000184	0.000654	CcSEcCtD
Etravirine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000183	0.0059	CbGpPWpGaD
Etravirine—Vomiting—Methylprednisolone—multiple sclerosis	0.000183	0.000652	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000182	0.00586	CbGpPWpGaD
Etravirine—Rash—Triamcinolone—multiple sclerosis	0.000182	0.000648	CcSEcCtD
Etravirine—Dermatitis—Triamcinolone—multiple sclerosis	0.000182	0.000647	CcSEcCtD
Etravirine—Anorexia—Methotrexate—multiple sclerosis	0.000182	0.000647	CcSEcCtD
Etravirine—Rash—Methylprednisolone—multiple sclerosis	0.000182	0.000647	CcSEcCtD
Etravirine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000182	0.000646	CcSEcCtD
Etravirine—Headache—Triamcinolone—multiple sclerosis	0.000181	0.000644	CcSEcCtD
Etravirine—Headache—Methylprednisolone—multiple sclerosis	0.000181	0.000642	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—multiple sclerosis	0.000181	0.000642	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—multiple sclerosis	0.000181	0.000642	CcSEcCtD
Etravirine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00018	0.000638	CcSEcCtD
Etravirine—Diarrhoea—Betamethasone—multiple sclerosis	0.00018	0.000638	CcSEcCtD
Etravirine—Dizziness—Dexamethasone—multiple sclerosis	0.000173	0.000617	CcSEcCtD
Etravirine—Dizziness—Betamethasone—multiple sclerosis	0.000173	0.000617	CcSEcCtD
Etravirine—Insomnia—Methotrexate—multiple sclerosis	0.000173	0.000614	CcSEcCtD
Etravirine—Nausea—Triamcinolone—multiple sclerosis	0.000172	0.000611	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—multiple sclerosis	0.000171	0.00061	CcSEcCtD
Etravirine—Nausea—Methylprednisolone—multiple sclerosis	0.000171	0.000609	CcSEcCtD
Etravirine—Somnolence—Methotrexate—multiple sclerosis	0.00017	0.000603	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000169	0.00542	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000169	0.00542	CbGpPWpGaD
Etravirine—Hypersensitivity—Prednisone—multiple sclerosis	0.000168	0.000598	CcSEcCtD
Etravirine—Vomiting—Betamethasone—multiple sclerosis	0.000167	0.000593	CcSEcCtD
Etravirine—Vomiting—Dexamethasone—multiple sclerosis	0.000167	0.000593	CcSEcCtD
Etravirine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000166	0.00535	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000166	0.00535	CbGpPWpGaD
Etravirine—Decreased appetite—Methotrexate—multiple sclerosis	0.000166	0.00059	CcSEcCtD
Etravirine—ABCB4—Metabolism—RRM1—multiple sclerosis	0.000166	0.00533	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000166	0.00533	CbGpPWpGaD
Etravirine—Rash—Dexamethasone—multiple sclerosis	0.000165	0.000588	CcSEcCtD
Etravirine—Rash—Betamethasone—multiple sclerosis	0.000165	0.000588	CcSEcCtD
Etravirine—Dermatitis—Betamethasone—multiple sclerosis	0.000165	0.000587	CcSEcCtD
Etravirine—Dermatitis—Dexamethasone—multiple sclerosis	0.000165	0.000587	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000165	0.000586	CcSEcCtD
Etravirine—Fatigue—Methotrexate—multiple sclerosis	0.000165	0.000585	CcSEcCtD
Etravirine—Headache—Dexamethasone—multiple sclerosis	0.000164	0.000584	CcSEcCtD
Etravirine—Headache—Betamethasone—multiple sclerosis	0.000164	0.000584	CcSEcCtD
Etravirine—Asthenia—Prednisone—multiple sclerosis	0.000164	0.000583	CcSEcCtD
Etravirine—Pain—Methotrexate—multiple sclerosis	0.000163	0.00058	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000157	0.000559	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—multiple sclerosis	0.000156	0.000556	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000156	0.000555	CcSEcCtD
Etravirine—Nausea—Dexamethasone—multiple sclerosis	0.000156	0.000554	CcSEcCtD
Etravirine—Nausea—Betamethasone—multiple sclerosis	0.000156	0.000554	CcSEcCtD
Etravirine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000154	0.00494	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000154	0.00494	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000152	0.00488	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000152	0.00488	CbGpPWpGaD
Etravirine—Dizziness—Prednisone—multiple sclerosis	0.000151	0.000537	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—multiple sclerosis	0.000151	0.000537	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—multiple sclerosis	0.000151	0.000537	CcSEcCtD
Etravirine—Vomiting—Prednisone—multiple sclerosis	0.000145	0.000516	CcSEcCtD
Etravirine—Rash—Prednisone—multiple sclerosis	0.000144	0.000512	CcSEcCtD
Etravirine—Dermatitis—Prednisone—multiple sclerosis	0.000144	0.000512	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000144	0.00462	CbGpPWpGaD
Etravirine—Headache—Prednisone—multiple sclerosis	0.000143	0.000509	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000141	0.0005	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.00014	0.00449	CbGpPWpGaD
Etravirine—Asthenia—Methotrexate—multiple sclerosis	0.000137	0.000487	CcSEcCtD
Etravirine—Nausea—Prednisone—multiple sclerosis	0.000136	0.000482	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000134	0.00429	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000132	0.00426	CbGpPWpGaD
Etravirine—Diarrhoea—Methotrexate—multiple sclerosis	0.000131	0.000464	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000129	0.00414	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000127	0.00409	CbGpPWpGaD
Etravirine—Dizziness—Methotrexate—multiple sclerosis	0.000126	0.000449	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000126	0.00404	CbGpPWpGaD
Etravirine—Vomiting—Methotrexate—multiple sclerosis	0.000121	0.000432	CcSEcCtD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000121	0.0039	CbGpPWpGaD
Etravirine—Rash—Methotrexate—multiple sclerosis	0.00012	0.000428	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—multiple sclerosis	0.00012	0.000428	CcSEcCtD
Etravirine—Headache—Methotrexate—multiple sclerosis	0.00012	0.000425	CcSEcCtD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000115	0.00369	CbGpPWpGaD
Etravirine—Nausea—Methotrexate—multiple sclerosis	0.000113	0.000403	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000111	0.00355	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000111	0.00355	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000103	0.00332	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000101	0.00326	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000101	0.00326	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000101	0.00324	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0001	0.00322	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0001	0.00322	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.95e-05	0.0032	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9.76e-05	0.00314	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9.76e-05	0.00314	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—BCHE—multiple sclerosis	9.52e-05	0.00306	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	9.5e-05	0.00305	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	9.29e-05	0.00299	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.81e-05	0.00283	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.75e-05	0.00281	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.7e-05	0.0028	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.6e-05	0.00277	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.03e-05	0.00258	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.86e-05	0.00253	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.26e-05	0.00233	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.14e-05	0.0023	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.51e-05	0.00209	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.48e-05	0.00208	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.48e-05	0.00208	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.46e-05	0.00208	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.29e-05	0.00202	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.9e-05	0.0019	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.9e-05	0.0019	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.84e-05	0.00188	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.74e-05	0.00185	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—APOE—multiple sclerosis	5.73e-05	0.00184	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.3e-05	0.0017	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.12e-05	0.00165	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.1e-05	0.00164	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.05e-05	0.00162	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—POMC—multiple sclerosis	4.92e-05	0.00158	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.9e-05	0.00158	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALB—multiple sclerosis	4.49e-05	0.00144	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.32e-05	0.00139	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.29e-05	0.00138	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.09e-05	0.00132	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SRM—multiple sclerosis	4e-05	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.98e-05	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.87e-05	0.00125	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.79e-05	0.00122	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SRM—multiple sclerosis	3.73e-05	0.0012	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.72e-05	0.00119	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.46e-05	0.00111	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.42e-05	0.0011	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.88e-05	0.000927	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.88e-05	0.000927	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.82e-05	0.000906	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.81e-05	0.000905	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.81e-05	0.000905	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.64e-05	0.000848	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.63e-05	0.000845	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.63e-05	0.000845	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.57e-05	0.000828	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.57e-05	0.000826	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.46e-05	0.000791	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.41e-05	0.000773	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.28e-05	0.000733	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000703	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.13e-05	0.000686	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000641	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.97e-05	0.000633	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.96e-05	0.000631	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.93e-05	0.000619	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.83e-05	0.000589	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000558	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000558	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.7e-05	0.000545	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.59e-05	0.00051	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.55e-05	0.000497	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.46e-05	0.000468	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	0.000427	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.33e-05	0.000427	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000423	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000404	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.23e-05	0.000396	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.000394	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.21e-05	0.000389	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000368	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—multiple sclerosis	7.55e-06	0.000243	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.55e-06	0.000243	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—multiple sclerosis	7.37e-06	0.000237	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—multiple sclerosis	6.89e-06	0.000221	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.49e-06	0.000209	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—multiple sclerosis	6.33e-06	0.000204	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—multiple sclerosis	5.92e-06	0.00019	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—multiple sclerosis	5.91e-06	0.00019	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—multiple sclerosis	5.77e-06	0.000186	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—multiple sclerosis	5.39e-06	0.000173	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.54e-06	0.000146	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.9e-06	0.000125	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.56e-06	0.000114	CbGpPWpGaD
